CBMG
$18.39
Cellular Biomedicine
($.01)
(.05%)
CBMG
Earnings Whisper ®
N/A
3rd Quarter September 2020
Consensus:  $0.00
Revenue:  $0.00 Mil
Wednesday
Nov 4
4:30 PM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch

What do you expect when CBMG reports earnings?
Beat
Meet
Miss

Where is CBMG's stock price going from here?
Up
Flat
Down
Stock chart of CBMG
Analysts
Summary of analysts' recommendations for CBMG
Score
Grade
Pivots
Resistance
-
-
-

-

Support
-
-
-
Tweet
Growth
Description
Cellular Biomedicine Group Inc. is a biomedicine firm engaged in the development of new treatments for degenerative and cancerous diseases utilizing proprietary cell therapy technologies. The Company offers developmental stem cell, progenitor cell, and immune cell projects. It is developing treatments utilizing proprietary cell technologies for the treatment of a range of cancers; joint disease and central nervous system diseases. Cellular Biomedicine Group Inc. is headquartered in Palo Alto, California.